Anti-COVID-19 efficacy of ivermectin in the golden hamster

GD de Melo, F Lazarini, F Larrous, L Feige, L Kergoat… - BioRxiv, 2020 - biorxiv.org
The devastating coronavirus disease 2019 (COVID-19) pandemic, due to SARS-CoV-2, has
caused more than 47 million confirmed cases and more than 1.2 million human deaths …

A nomogram to predict the risk of unfavourable outcome in COVID-19: a retrospective cohort of 279 hospitalized patients in Paris area

Y Nguyen, F Corre, V Honsel, S Curac… - Annals of …, 2020 - Taylor & Francis
Objective To identify predictive factors of unfavourable outcome among patients hospitalized
for COVID-19. Methods We conducted a monocentric retrospective cohort study of COVID …

An experimental test of the nicotinic hypothesis of COVID-19

NE Godellas, GD Cymes… - Proceedings of the …, 2022 - National Acad Sciences
The pathophysiological mechanisms underlying the constellation of symptoms that
characterize COVID-19 are only incompletely understood. In an effort to fill these gaps, a …

Current use of ivermectin in dermatology, tropical medicine, and COVID-19: an update on pharmacology, uses, proven and varied proposed mechanistic action

SR Mathachan, K Sardana… - Indian dermatology online …, 2021 - journals.lww.com
Ivermectin is a broad-spectrum antiparasitic drug with anti-inflammatory, anti-viral, anti-
bacterial, and anti-tumor effects. In this review, we discuss the history, pharmacology …

Carbon dioxide and MAPK signalling: towards therapy for inflammation

H Gałgańska, W Jarmuszkiewicz… - Cell Communication and …, 2023 - Springer
Inflammation, although necessary to fight infections, becomes a threat when it exceeds the
capability of the immune system to control it. In addition, inflammation is a cause and/or …

<? covid19?> Management of clozapine treatment during the COVID-19 pandemic

S Gee, F Gaughran, J MacCabe… - Therapeutic …, 2020 - journals.sagepub.com
Clozapine is the only available treatment for refractory schizophrenia but its use involves
frequent physical contact with healthcare workers for the purpose of mandatory blood …

COVID-19: Pathogenesis of a multi-faceted disease

V Bonny, A Maillard, C Mousseaux… - La Revue de …, 2020 - europepmc.org
Résumé L'infection par le SARS-CoV-2, nommée COVID-19, peut conduire à une réaction
immunitaire inadaptée et à une coagulopathie responsables d'un véritable sepsis viral …

Smoking, vaping, and tobacco industry during COVID-19 pandemic: Twitter data analysis

M Kamiński, A Muth, P Bogdański - … , Behavior, and Social …, 2020 - liebertpub.com
The reports suggesting a beneficial effect of nicotine on coronavirus disease 2019 (COVID-
19) severity may encourage smoking. We aimed to analyze tweets on COVID-19 and …

[HTML][HTML] Ivermectin in mild and moderate COVID-19 (RIVET-COV): a randomized, placebo-controlled trial

A Mohan, P Tiwari, T Suri, S Mittal, A Patel, A Jain… - 2021 - europepmc.org
Objectives: To determine if a single oral administration of Ivermectin to patients with mild and
moderate COVID-19 is effective in converting SARS-CoV-2 RT-PCR to negative result and …

Mitochondrial nicotinic acetylcholine receptors: Mechanisms of functioning and biological significance

M Skok - The International Journal of Biochemistry & Cell …, 2022 - Elsevier
Nicotinic acetylcholine receptors mediate fast synaptic transmission in neuro-muscular
junctions and autonomic ganglia and modulate survival, proliferation and neurotransmitter …